Gene: ATG101
Official Full Name: autophagy related 101provided by HGNC
Gene Summary: Enables identical protein binding activity. Involved in autophagosome assembly; negative regulation of cell population proliferation; and regulation of protein lipidation. Located in phagophore assembly site. Part of Atg1/ULK1 kinase complex. Biomarker of cholangiocarcinoma; colon cancer; and hepatocellular carcinoma. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09356 | ATG101 Knockout cell line (HeLa) | Human | ATG101 | 1:3~1:6 | Negative | Online Inquiry |
KO09357 | ATG101 Knockout cell line (HCT 116) | Human | ATG101 | 1:2~1:4 | Negative | Online Inquiry |
KO09358 | ATG101 Knockout cell line (HEK293) | Human | ATG101 | 1:3~1:6 | Negative | Online Inquiry |
KO09359 | ATG101 Knockout cell line (A549) | Human | ATG101 | 1:3~1:4 | Negative | Online Inquiry |
ATG101 Gene Knockout Cell Lines are specially engineered cellular models designed to elucidate the molecular mechanisms underlying autophagy and cellular stress responses. Utilizing CRISPR-Cas9 technology, these cell lines have specifically disrupted the ATG101 gene, an essential component involved in the formation of autophagosomes. The knockout of ATG101 allows researchers to observe the direct consequences of impaired autophagy, thereby providing insight into how disruptions in this process can lead to various diseases, including cancer, neurodegenerative disorders, and infectious diseases.
The key function of ATG101 is to serve as a regulatory element in autophagy, influencing the recruitment of other autophagy-related proteins and aiding in the initiation of autophagosome formation. By studying these knockout cell lines, researchers can dissect the intricate signaling pathways that regulate cellular homeostasis, evaluate the role of autophagy in disease progression, and explore potential therapeutic strategies aimed at modulating this critical cellular process.
Scientifically, the availability of ATG101 Gene Knockout Cell Lines holds significant value in research and clinical settings. They are valuable tools for drug discovery, enabling the identification of compounds that may restore autophagic function. Furthermore, these cell lines can be instrumental in understanding the role of autophagy in responses to various stimuli, such as nutrient deprivation, oxidative stress, and therapeutic agents.
What sets ATG101 Gene Knockout Cell Lines apart from alternative models is their precise genetic modification, which ensures reproducibility and reliability in experimental outcomes. Additionally, they are compatible with a variety of assays, including flow cytometry, western blotting, and high-content screening, thus providing versatility in their application.
In conclusion, ATG101 Gene Knockout Cell Lines offer an unprecedented opportunity for researchers and clinicians to explore the biology of autophagy in a controlled manner. Their ability to facilitate high-impact discoveries underscores their relevance to the scientific community. Our company prides itself on its commitment to providing high-quality biological products, backed by extensive expertise in genetic engineering and cellular biology, ensuring that our customers receive reliable and innovative tools for their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.